Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2014 Mar;120(3):579-89.
doi: 10.1097/ALN.0000000000000087.

Etomidate use and postoperative outcomes among cardiac surgery patients

Affiliations

Etomidate use and postoperative outcomes among cardiac surgery patients

Chad E Wagner et al. Anesthesiology. 2014 Mar.

Abstract

Background: Although a single dose of etomidate can cause relative adrenal insufficiency, the impact of etomidate exposure on postoperative outcomes is unknown. The objective of this study was to examine the association between a single induction dose of etomidate and clinically important postoperative outcomes after cardiac surgery.

Methods: The authors retrospectively examined the association between etomidate exposure during induction of anesthesia and postoperative outcomes in patients undergoing cardiac surgery from January 2007 to December 2009 by using multivariate logistic regression analyses and Cox proportional hazards regression analyses. Postoperative outcomes of interest were severe hypotension, mechanical ventilation hours, hospital length of stay, and in-hospital mortality.

Results: Sixty-two percent of 3,127 patients received etomidate. Etomidate recipients had a higher incidence of preoperative congestive heart failure (23.0 vs. 18.3%; P = 0.002) and a lower incidence of preoperative cardiogenic shock (1.3 vs. 4.0%; P < 0.001). The adjusted odds ratio for severe hypotension and in-hospital mortality associated with receiving etomidate was 0.80 (95% CI, 0.58-1.09) and 0.75 (95% CI, 0.45-1.24), respectively, and the adjusted hazard ratio for time to mechanical ventilation removal and time to hospital discharge was 1.10 (95% CI, 1.00-1.21) and 1.07 (95% CI, 0.97-1.18), respectively. Propensity score analysis did not change the association between etomidate use and postoperative outcomes.

Conclusions: In this study, there was no evidence to suggest that etomidate exposure was associated with severe hypotension, longer mechanical ventilation hours, longer length of hospital stay, or in-hospital mortality. Etomidate should remain an option for induction of anesthesia in cardiac surgery patients.

PubMed Disclaimer

Conflict of interest statement

The authors declare no competing interests

Figures

Fig. 1
Fig. 1
Severe Hypotension Regression Analysis: Results are based on a multivariable logistic regression model, and odds ratios (OR) and 95% confidence intervals summarize the relative odds of severe hypotension. Calendar month, body mass index (BMI) and creatinine concentration were entered into the regression model flexibly using restricted cubic splines with four knots. To display effects sizes for the nonlinear effects, we chose a single reference value for each variable (calendar month = July 2008, BMI = 30 kg/m2, creatinine concentration = 1 mg/dl) and compared all other values to it. Due to lack of evidence suggesting a nonlinear relationship with any of the outcomes, the other continuous variables (age and ejection fraction) were modeled with linear terms and are included on the right with categorical variables. Categorical variables effects characterize the adjusted association between the outcome and the presence (vs. absence) of the risk factor. ACE = angiotensin-converting enzyme; CABG = coronary artery bypass graft; CHF = congestive heart failure.
Fig. 2
Fig. 2
Time to Mechanical Ventilation (MV) Removal Regression Analysis: Results are based on a multivariable Cox proportional hazards model, and hazard ratios (HR) and 95% confidence intervals summarize the relative rates at which MV was removed. Calendar month, body mass index (BMI) and creatinine concentration were entered into the regression model flexibly using restricted cubic splines with four knots. To display effects sizes for the nonlinear effects, we chose a single reference value for each variable (calendar month = July 2008, BMI = 30 kg/m2, creatinine concentration = 1 mg/dl) and compared all other values to it. Due to lack of evidence suggesting a nonlinear relationship with any of the outcomes, the other continuous variables (age and ejection fraction) were modeled with linear terms and are included on the right with categorical variables. Categorical variable effects characterize the adjusted association between the outcome and the presence (vs. absence) of the risk factor. Note that HR greater than (less than) one implies shorter (longer) time on MV. ACE = angiotensin-converting enzyme; CABG = coronary artery bypass graft; CHF = congestive heart failure.
Fig. 3
Fig. 3
Time to Hospital Discharge Regression Analysis: Results are based on a multivariable Cox proportional hazards model, and hazard ratios (HR) and 95% confidence intervals summarize the relative rates at which patients were discharged from the hospital. Calendar month, body mass index (BMI) and creatinine concentration were entered into the regression model flexibly using restricted cubic splines with four knots. To display effects sizes for the non-linear effects, we chose a single reference value for each variable (calendar month = July 2008, BMI = 30 kg/m2, creatinine concentration = 1 mg/dl) and compared all other values to it. Due to lack of evidence suggesting a nonlinear relationship with any of the outcomes, the other continuous variables (age and ejection fraction) were modeled with linear terms and are included on the right with categorical variables. Categorical variable effects characterize the adjusted association between the outcome and the presence (vs. absence) of the risk factor. Note that HR greater than (less than) one implies shorter (longer) length of stay. ACE = angiotensin-converting enzyme; CABG = coronary artery bypass graft; CHF = congestive heart failure.
Fig. 4
Fig. 4
In Hospital Mortality Regression Analysis: Results are based on a multivariable logistic regression model, and odds ratios (OR) and 95% confidence intervals summarize the relative odds of mortality during the hospitalization. Calendar month, body mass index (BMI) and creatinine concentration were entered into the regression model flexibly using restricted cubic splines with four knots. To display effects sizes for the nonlinear effects, we chose a single reference value for each variable (calendar month = July 2008, BMI = 30 kg/m2, creatinine concentration = 1 mg/dl) and compared all other values to it. Due to lack of evidence suggesting a nonlinear relationship with any of the outcomes, the other continuous variables (age and ejection fraction) were modeled with linear terms and are included on the right with categorical variables. Categorical variables effects characterize the adjusted association between the outcome and the presence (vs. absence) of the risk factor. ACE = angiotensin-converting enzyme; CABG = coronary artery bypass graft; CHF = congestive heart failure.

Comment in

  • Etomidate and treatment propensity.
    Sanders RD, Pickworth T, Okoli G, Venkatesan S, Myles P. Sanders RD, et al. Anesthesiology. 2014 Nov;121(5):1128. doi: 10.1097/ALN.0000000000000417. Anesthesiology. 2014. PMID: 25335175 No abstract available.
  • In reply.
    Schildcrout JS, Han X, Ehrenfeld JM, Wagner CE, Pretorius M. Schildcrout JS, et al. Anesthesiology. 2014 Nov;121(5):1128-30. doi: 10.1097/ALN.0000000000000418. Anesthesiology. 2014. PMID: 25335176 No abstract available.

References

    1. Budde AO, Mets B. Pro: Etomidate is the ideal induction agent for a cardiac anesthetic. J Cardiothorac Vasc Anesth. 2013;27:180–3. - PubMed
    1. Cuthbertson BH, Sprung CL, Annane D, Chevret S, Garfield M, Goodman S, Laterre PF, Vincent JL, Freivogel K, Reinhart K, Singer M, Payen D, Weiss YG. The effects of etomidate on adrenal responsiveness and mortality in patients with septic shock. Intensive Care Med. 2009;35:1868–76. - PubMed
    1. Hohl CM, Kelly-Smith CH, Yeung TC, Sweet DD, Doyle-Waters MM, Schulzer M. The effect of a bolus dose of etomidate on cortisol levels, mortality, and health services utilization: A systematic review. Ann Emerg Med. 2010;56:105–13. e5. - PubMed
    1. Albert SG, Ariyan S, Rather A. The effect of etomidate on adrenal function in critical illness: A systematic review. Intensive Care Med. 2011;37:901–10. - PubMed
    1. Absalom A, Pledger D, Kong A. Adrenocortical function in critically ill patients 24 h after a single dose of etomidate. Anaesthesia. 1999;54:861–7. - PubMed

Publication types